Author: admin

The community reinforces the effects of heat and health information.

|

The community reinforces the information on the effects of heat and health.

Alemany presented the brochures with tips for minimizing the effects of the heat.

-up to the 15 of September will be operating the Plan of prevention of the effects of heat

Madrid, August of 2011- the community of Madrid has strengthened the information directed to the citizen to adopt preventive measures to minimize the effects of high temperatures on health with distribution since last July in the centros de salud de la Comunidad de Madrid of brochureson 4 August presented the director-general of primary care, Antonio Alemany.

Brochures contain graphically basic advice concerning the desirability of staying hydrated, and increasing consumption of fruits and vegetables, as well as protect especially infants and the elderly. Also, please avoid doing sport and physical efforts in the hottest hours.

Alemany recalled that in the case that you are taking medication and the patient perceive no common symptoms, consult with your doctor or nurse at the health centre. In any case, it was stressed that any emergencies caused by heat citizen must ask for help on phone 112.

Information the citizen to deal with the effects of the heat is part of Plan of early warning and prevention of the effects on the health of the heat wave that has enabled the community of Madrid until 15 September.

The Prevention Plan is aimed at the most vulnerable to the effects of the heat, who are the elderly, persons with cardiovascular or respiratory diseases and children. This group included elders living alone, with little support socio-familial, sick people or people with disadvantaged socio-economic situation. Also because of their vulnerability, it is directed to the protection of minors.

To facilitate the accessibility of information, the Ministry of health has created a specific web site that includes a temperature newsletter that will inform via icons in the form of Sun of the level of risk along with the prediction of the situation of the four heat days. From this entry on the Internet, anyone interested can subscribe to the service of receipt of such newsletters.

Levels of risk

The Ministry of health has set up different levels of risk taking as reference the value of 36.5 ° C, from which the alert is activated by heat, to the socio-sanitary institutions optimize their resources in anticipation of increased demand of the susceptible population and strengthen their systems of care to olderbasically.

This is the so-called “ temperature threshold ”, which, according to the studies of the community of Madrid, can cause both direct effects on the heat, the most serious being what is known as heat stroke, as well as indirect effects in elderly and chronically ill. In some cases, the high temperatures alter existing pathologies such as cardiovascular and respiratory disease symptoms.

To cope with the high temperatures, experts from the Ministry of health recommend eating at least two liters of water and liquids, juices or isotonic drinks, but not alcohol to prevent dehydration and protect from the Sun at the maximum insolation hours, avoiding intense sporting activities.

They also advise that if you have been exposed to the Sun or intense heat and presents a table with high fever, skin hot, red, dry, call 112, because they can suffer a heat stroke. If so, it can be a serious situation that requires urgent attention.

On the other hand, those patients with endocrine, heart or lung disease should keep well hydrated and take care of its pharmacological treatment. Similarly, parents should keep well hydrated babies and sites frescoes.

Read More

The number of people vaccinated in the unity of the traveller of the Hospital Carlos III rose 26.5% in 2010.

|

The number of people vaccinated in the unity of the traveller of the Hospital Carlos III rose 26.5% in 2010.

according to the study done by the Centre, can travel for tourism and the destinations are India, Kenya and Viet Nam.

-In 2010, the traveler’s unit administered 23.448 vaccines to 8.643 people who visited the foreign

-this hospital is the only Center that offers comprehensive care before and after the trip for adults and children

Madrid, July of 2011- the Hospital Carlos III of Madrid has carried out a study that reveals that last year increased by 26.5% the number of people that he came to vaccinate traveler’s unit of the hospital.

Data have been obtained from the population that has attended during 2010 the consultations of the unity of the traveller of the Hospital Carlos III, specializing in the health care prior to the trip. This unit spent the last year a total of 8.643 people, with 6.830 in 2009, which was administered 23.448 vaccines, which represents an average of two and three vaccines for travelers.

The necessary vaccines for travel, hepatitis A was which was administered in the Carlos III Hospital in 2010, with 23% of the total. The vaccine against yellow fever was administered to 14 per cent of travellers, followed with a 12.5% tetanus and typhoid fever with 10%.

In addition, 74 per cent of travellers pointed out prophylaxis against malaria or malaria.

According to the hospital, 52% of the travel are made by tourism or adventure, 14% of people who do it for work or 12% that travels through international cooperation. Almost half of these trips, 46 per cent, lasts between fifteen and thirty days.

The study also stresses that travel more women and that their average age around 37 years. Also, the continent preferred in 2010 was Africa, with 39% of trips, followed by Asia, elected by 35 per cent of travellers and South America by 25%. However, the country most visited last year was India, which garnered 15% of travellers, doubling its immediate follower Kenya, which was around 7% of travellers.

They follow them Viet Nam and Peru with 4.5 per cent of outputs carried out abroad in 2010.

Integral and personalized care

Traveler’s unit is integrated into section of Tropical Medicine of the service of infectious diseases at the Hospital Carlos III. This unit offers a comprehensive care prior to travel in a single query custom with a doctor who specializes in tropical pathology. The optional offers travel tips higiénico-sanitarios and food for the journey and prescribe treatments and the required vaccines for the prevention of the diseases present in risk countries. All of this, depending on the destination, duration and type of travel and the clinical history of each.

the Hospital Carlos III is Center of reference in vaccination

international and tropical diseases. It is the only Center in Spain that offers health care before the trip to children and adults, consultation and hospitalization in tropical diseases, CITES telephone and Internet and a website with a database on countries with health risk.

This online service is accessed via the address saludviajero. Since the Hospital Carlos III recalls that it is advisable to request appointment as contracted travel and go to the traveler’s unit between one and two months before the departure to areas with a health risk to the proper administration of the vaccines and preventive treatments. It is also recommended to report in specialized centres of the health needs of the country you plan to visit.

Read More

Malaria affects 2,850 million people around the world already.

|

Malaria already affects 2,850 million people around the world.

Spain, 2011-February global vaccination campaign against malaria. The SciNet Corporation is distributing medical emergency and units of mass vaccination, as well as other specialities like ophthalmology, dentistry, obstetrics and electromedical.

Emergency medical units have everything you need to operate with autonomy even in places that lack of any infrastructure. In addition to responding to medical emergencies, these containers serve specialties such as electromedical equipment, ophthalmology, dentistry and obstetrics. Also, include a module with machine vending supplying consumable sanitary serum, syringes, tweezers, pharmaceutical materials, etc.

These units will be complemented by mini-plantas of production, which are fully equipped containers to provide all kinds of products and services: food, drinking water, shoes, clothes, etc. As well as emergency medical units, each container includes machines, cables, pipes and facilities required to operate with autonomy.

Also distributed more than 2,000,000 through digital certificates ‘ chipless ’ radio frequency (RFID), being provided to over 20 million during the next six months. Devices ‘ chipless ’ are being distributed in developing countries and regions of the world of high risk, as well as natural disasters and can be used immediately for the acquisition of all kinds of first necessity products produced by the Mini-plantas (drinking water, bread, dehydrated foods)(, medicines and medical supplies, dairy products, etc.).

Malaria Atlas Project
SciNet Corporation
SCINETCORP Foundation

Read More

The PATH initiative for the vaccine against Malaria, MSD and the Langone of the University of New York Medical Center are collaborating in the investigation of a possible vaccine against malaria.

|

The initiative PATH for the vaccine against Malaria, MSD and the Langone of the University of New York Medical Center are collaborating in the investigation of a possible vaccine against the malaria

researchers try to block the activity of key proteins to prevent the malaria parasite in the liver

Bethesda, M.D., Whitehouse Station, N.J., New York, December of 2010. The development of a vaccine to prevent the malaria parasite is introduced in the human liver is the goal of a new partnership announced by world leaders in research and development of vaccines. The PATH initiative for vaccine against Malaria (MVI), MSD (known in the United States.)UU. (and Canada as Merck & Co) and the Centre medical Langone of the University of New York (NYU) collaborate to evaluate a strategy which takes a novel part of a major surface protein as diana in the malaria parasite. It is estimated that malaria is responsible for the deaths of nearly 900,000 people per year and that most of these relate to children under five in sub-Saharan Africa.

It was discovered that circumsporozoito (CSP) protein is a potential target in focus in the early stages of infection by malaria vaccine development. Researchers working in this project are focusing their efforts on a new strategy that has a region of the CSP that is important for a critical function of the protein as diana. It is expected that blocking this function, it can prevent liver invasion by the parasite, which is an essential phase that causes the disease of malaria.

“ Believe that we can improve the way in which vaccines are designed virosome strategically addressing this very important protein function ”, indicated the DRA. Elizabeth Nardin, Professor of the Department of medical parasitology in the NYU Langone Medical Center. “ Other approaches to get directed to the CSP vaccine have required extremely high antibody levels, and they are difficult to obtain and maintain. “This approach has the potential to remedy this problem.”

The justification for this targeted strategy of “ conjugate of peptides and proteins ” is based on the knowledge of the technology of vaccines to be used in the determination of a specific protein of malaria is known to cause an immune response. It has already shown that the CPS has an important protective efficacy in practice, in the context of the RTS, S vaccine most advanced candidate who is currently in a phase III clinical trial. In addition, MSD has included other vaccines based on conjugate that they have been developed against bacterial pathogens in pediatric vaccines approved and widely used.

“ History has shown that the vaccines can be a powerful tool against diseases, ” stated Dr. John Shiver, Vice President of discovery of vaccines of MSD. “ agree that the new methods and consortia, as this collaboration with MVI and the NYU Langone Medical Center, they are important to continue to innovate in the battle against the malaria parasite ”.

“ With the availability of a first generation malaria vaccine in perspective, we are increasing our efforts to find and fund scientific approaches for malaria vaccines that have the potential to be more efficient and protect more people ” explained Dr. Christian Loucq, director of MVI. “ we are very pleased that one of the largest pharmaceutical laboratories in the world and a Center medical academic have undertaken to test a promising new way to protect children from malaria ”.

Although this vaccine is being tested primarily for use in children under the age of one year, could be used to prevent disease in vulnerable to Plasmodium falciparum, the deadliest species of parasite, and potentially could be adapted to also prevent P. vivax. Approximately 40% of the world’s population living at risk of contracting malaria because of p. vivax or p. falciparum.

“ Though it is still quite early, we are delighted to have the opportunity to explore the promise of this innovative vaccine with MSD and MVI ”, noted Dr. Photini Sinnis, adjunct professor in medical parasitology in Center doctor Langone of the NYU.

On the PATH initiative for vaccine against Malaria (MVI)

The PATH initiative for the vaccine against Malaria (MVI) is a program on a global scale PATH established in 1999 with an initial grant from the Bill & Melinda Gates Foundation. MIV mission is to accelerate the development of malaria vaccines and ensure their availability and accessibility in developing countries. MVI vision is to achieve a world free of malaria.

On PATH

PATH is an international non-profit which creates solutions sustainable, culturally relevant, thus enabling communities worldwide to ending cycles of long-term ill-health. Through collaboration with various public and private sector institutions, PATH helps provide appropriate vital strategies that change the way in which people thinks and acts and health technology. The work of PATH improves the health and well-being around the world.

On the NYU Langone Medical Center

The Langone medical center of NYU , an academic medical center integrated global quality focused on patients, is one of the main centres of the United States.UU. for excellence in health care, biomedical research and medical education. Located in Midtown Manhattan, the NYU Langone Medical Center consists of three hospitals – Tisch Hospital, a tertiary facility in intensive care with 705 beds; the Institute of Medicine of rehabilitation Rusk, the first rehabilitation hospital in the world, with 174 beds and extensive programmes of rehabilitation for patients travelling, and the Hospital for diseases of the joints, there are 190 beds and it is one of the five hospitals in the world dedicated to the trauma and the Rheumatology – in addition to the Faculty of Medicine of the University of New York, one of the most prominent academic institutions of EE.U.S.

About MSD

now MSD is a leader in global health who works to contribute to global health. MSD is known as Merck in United States and Canada. Through our medicines, vaccines, biological therapies and consumption and veterinary products, we work with our clients operating in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increase access to health care through programmes of long range that they donate and deliver our products to the people who need it.

Read More

GlaxoSmithKline and Fiocruz extend their cooperation to research and develop new drugs for tropical diseases unknown.

|

GlaxoSmithKline and Fiocruz extend their cooperation to research and develop new drugs for tropical diseases unknown.

Spain, November 2010- GlaxoSmithKline and the Oswaldo Cruz Foundation (Fiocruz) have announced the expansion of its partnership to research and develop new drugs to treat diseases affecting the population of the countries most underdeveloped.

This new framework of collaboration is based on a relationship between Fiocruz and GlaxoSmithKline established in 1985 to make priority vaccines for the Brazilian public health, as well as those intended to immunize people against polio, Haemophilus influenzae type b (Hib), mumps, rubella, measles, rotavirus, and most recently, disease-related pneumonia. Furthermore, this relationship has also supported the development of research and manufacturing in Brazil through technology transfer and scientific collaboration.

The extension of the agreement between the two entities will allow scientists of Fiocruz and GSK’s Tres Cantos Madrid, sharing of research results, display new ideas and knowledge in areas such as Malaria, Tuberculosis, Chagas disease and Leishmaniasis. In this way, the agreement will focus on Chagas disease and Leishmaniasis due to the experience of Fiocruz in these diseases and the heavy burden of medical needs of people suffering from these diseases.

The new Alliance will be based on the strategy of open innovation of GSK, which aims to foster partnerships, offering access to the infrastructure, processes and the experience of the scientists working in Tres Cantos and Fiocruz.

As explained Dr. Nick Cammack, SVP and Head of the Tres Cantos Medicines Development Campus: “ in GSK are committed to collaboration in the search for new treatments for many diseases that affect millions of people in much of the world ”.

On the other hand, Fiocruz ’ s Vice President of Production and Innovation, Dr. Carlos Gadelha, pointed out that “ this agreement with Tres Cantos, Fiocruz will expand partnership with GSK with the aim of discovering and developing new drugs against unknown diseases. In this way, will meet the recognised experience of both institutions in an area of great impact on public health ”.

About GSK

Medicines development, Tres Cantos is dedicated to research and discovery of new drugs to combat diseases of countries in the process of developed. In January 2010, GSK set up the Lab Open Foundation non-profit. Open Lab Foundation was created to facilitate collaborations between schools and industry. GSK has made it possible that up to 60 scientists around the world have access to facilities of GSK in Tres Cantos. Also shared with external scientists – with funds from the Foundation Open Lab – skills, knowledge and infrastructure of the company, at the same time pursuing their own projects as part of an integrated team to discover new drugs.

On the Oswaldo Cruz Foundation (Fiocruz)

The Oswaldo Cruz Foundation (Fiocruz) was established on 25 may 1900, with the name of the Soroterapico Federal Institute. The Fiocruz mission was to combat the problems of public health of Brazil. For this reason, Fiocruz became an institution committed to the Brazilian reality and experimental medicine.

Promoting social development and health, develop and disseminate scientific and technological knowledge to be an agent of the citizenship, are concepts that have been linked to the Oswaldo Cruz Foundation with the Brazilian Ministry of health and the most important institutions of science and technology in health in Latin America.

Currently, Fiocruz is responsible for the development of research on the production of vaccines, drugs, reagents and kits for diagnosis. Their activity ranges from education and professional training, information and communication in health, science and technology; control of quality of products and services and the implementation of social programmes. It has more than 7,500 employees and professionals and researchers.

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips